English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu1. Adding travel history to patient evaluation could help to prevent spread of coronavirus Abstract: http://annals. org/ aim/ article/ doi/ 10. 7326/ M20-0643 URL goes live when the embargo lifts A commentary published in Annals of Internal Medicine recommends adding…
Tag: Vaccines
Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment. Professor Vincenzo Cerullo’s research team at the University of Helsinki discovered…
Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment. Professor Vincenzo Cerullo’s research team at the University of Helsinki discovered…
Scientists discover new ‘Jekyll and Hyde’ immune cell
Scientists at Trinity College Dublin have identified a rare, new cell in the immune system with “Jekyll and Hyde properties”. These cells play a key protective role in immunity to infection but – if unregulated – also mediate tissue damage…
Scientists discover new ‘Jekyll and Hyde’ immune cell
Scientists at Trinity College Dublin have identified a rare, new cell in the immune system with “Jekyll and Hyde properties”. These cells play a key protective role in immunity to infection but – if unregulated – also mediate tissue damage…
HKUST scientists shed light on COVID-19 vaccine development
A team of scientists at the Hong Kong University of Science and Technology (HKUST) has recently made an important discovery in identifying a set of potential vaccine targets for the SARS-CoV-2 coronavirus, providing crucial leads for guiding experimental efforts towards…
HKUST scientists shed light on COVID-19 vaccine development
A team of scientists at the Hong Kong University of Science and Technology (HKUST) has recently made an important discovery in identifying a set of potential vaccine targets for the SARS-CoV-2 coronavirus, providing crucial leads for guiding experimental efforts towards…
Using Social Media to Understand the Vaccine Debate in China
THE SITUATIONVaccine acceptance is a crucial public health issue, which has been exacerbated by the use of social media to spread content expressing vaccine hesitancy. Studies have shown that social media can provide new information regarding the dynamics of vaccine…
Adults don’t need tetanus, diphtheria boosters if fully vaccinated as children
US currently recommends booster shots for adults every 10 years
Adults don’t need tetanus, diphtheria boosters if fully vaccinated as children
US currently recommends booster shots for adults every 10 years
Microbiology Society’s Annual Conference biggest ever
More than 1,400 scientists from around the world will attend the five-day conference in Edinburgh to present their research
Electron microscopy allows scientists to understand the molecular trigger of allergic reactions
A research team has been able to describe the overall structure of the antibody type IgE, which is the key molecule in allergic diseases; this is a scientific breakthrough which provides important insights into basic mechanisms of allergic reactions
Microbiology Society’s Annual Conference biggest ever
More than 1,400 scientists from around the world will attend the five-day conference in Edinburgh to present their research
Electron microscopy allows scientists to understand the molecular trigger of allergic reactions
A research team has been able to describe the overall structure of the antibody type IgE, which is the key molecule in allergic diseases; this is a scientific breakthrough which provides important insights into basic mechanisms of allergic reactions
Tulane University launches new coronavirus research program to develop a vaccine and advanced diagnostics
From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.
Columbia University researchers awarded $2M to identify antiviral drugs for coronavirus
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus, 2019-nCoV. The funding was awarded by the Jack Ma Foundation,…
SwRI’s Rhodium™ virtually screens drugs for coronavirus research
Novel processing, machine learning improves compound scanning capacity for drug development
SwRI’s Rhodium™ virtually screens drugs for coronavirus research
Novel processing, machine learning improves compound scanning capacity for drug development
Vaccine misinformation and social media
People exposed to vaccine content on social media more likely misinformed than those exposed to it on traditional media
Atomic structures mapped in measles, mumps, flu and RSV
Discovery could give insight into coronavirus, which has similar features and functions
The (un)usual suspect — novel coronavirus identified
A recent study identifies the novel coronavirus responsible for the pneumonia epidemic in the Hubei province of China — the bat-origin virus is related to other known pathogenic coronaviruses
STDs on the rise: The evidence of claims data
Private insurance claim lines for STDs rose 76 % from 2007 to 2018
Blue Water Vaccines to develop strep pneumo vaccine from St. Jude Children’s research
Blue Water Vaccines licenses patent rights to streptococcus pneumoniae vaccine developed at St. Jude Children’s Research Hospital; fully attenuated vaccine aims to offer mucosal protection, cover all subtypes
Personalized cancer vaccines
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome. Firstly, since tumor mutations are unique to each patient, cancer cell antigens…
Trial shows using two drugs not better than one when treating MRSA blood infections
Researchers attempting to improve the treatment for methicillin-resistant Staphylococcus aureus (MRSA) blood infections have discovered the combination of two antibiotics was no better than one, and led to more adverse effects
New research shows how the malaria parasite grows and multiplies
Scientists have made a major breakthrough in understanding how the parasite that causes malaria is able to multiply at such an alarming rate, which could be a vital clue in discovering how it has evolved, and how it can be…
Rabies: New prophylactic and therapeutic avenues
Rabies is still responsible for approximately 60,000 human deaths per year mostly in Asia and Africa and affects especially underserved people. Yet, since the first vaccine developed by Louis Pasteur more than 130 years ago, prophylactic measures have significantly improved.…
Mass General Hospital researchers identify new ‘universal’ target for antiviral treatment
Mass General Hospital researchers identify new “universal” target for antiviral treatment BOSTON – As the coronavirus outbreak shows, viruses are a constant threat to humanity. Vaccines are regularly developed and deployed against specific viruses, but that process takes a lot…
Trial shows using two drugs not better than one when treating MRSA blood infections
Researchers attempting to improve the treatment for methicillin-resistant Staphylococcus aureus (MRSA) blood infections have discovered the combination of two antibiotics was no better than one, and led to more adverse effects
New research shows how the malaria parasite grows and multiplies
Scientists have made a major breakthrough in understanding how the parasite that causes malaria is able to multiply at such an alarming rate, which could be a vital clue in discovering how it has evolved, and how it can be…
STDs on the rise: The evidence of claims data
Private insurance claim lines for STDs rose 76 % from 2007 to 2018
Blue Water Vaccines to develop strep pneumo vaccine from St. Jude Children’s research
Blue Water Vaccines licenses patent rights to streptococcus pneumoniae vaccine developed at St. Jude Children’s Research Hospital; fully attenuated vaccine aims to offer mucosal protection, cover all subtypes
Personalized cancer vaccines
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome. Firstly, since tumor mutations are unique to each patient, cancer cell antigens…
Rabies: New prophylactic and therapeutic avenues
Rabies is still responsible for approximately 60,000 human deaths per year mostly in Asia and Africa and affects especially underserved people. Yet, since the first vaccine developed by Louis Pasteur more than 130 years ago, prophylactic measures have significantly improved.…
Mass General Hospital researchers identify new ‘universal’ target for antiviral treatment
Mass General Hospital researchers identify new “universal” target for antiviral treatment BOSTON – As the coronavirus outbreak shows, viruses are a constant threat to humanity. Vaccines are regularly developed and deployed against specific viruses, but that process takes a lot…
City of Hope’s Triplex vaccine reduces rate of CMV complications in transplant recipients
Results from a phase 2 randomized trial study published today in Annals of Internal Medicine
Penn State receives five-year $3.7 million grant to study virus evolution
The evolution of viruses will be the focus of a five-year $3.7 million dollar grant from the National Science Foundation’s new program on convergence research, to an interdisciplinary team led by Penn State. The grant is in two phases, depending…
City of Hope’s Triplex vaccine reduces rate of CMV complications in transplant recipients
Results from a phase 2 randomized trial study published today in Annals of Internal Medicine
Penn State receives five-year $3.7 million grant to study virus evolution
The evolution of viruses will be the focus of a five-year $3.7 million dollar grant from the National Science Foundation’s new program on convergence research, to an interdisciplinary team led by Penn State. The grant is in two phases, depending…
Cervical cancer elimination possible within two decades in the US
Boston, MA–Scaling up cervical cancer screening coverage in the U.S. to 90% could expedite elimination of the disease and avert more than 1,000 additional cases per year, according to a new study led by researchers from Harvard T.H. Chan School…
Cancer vaccine could boost the effectiveness of immunotherapy
Supercharging the mutation rate in cancer cells can create a powerful vaccine that is able to boost the effectiveness of immunotherapy, a major new study reports. Scientists forced cancer cells in the lab to evolve much more rapidly than usual…
Cancer vaccine could boost the effectiveness of immunotherapy
Supercharging the mutation rate in cancer cells can create a powerful vaccine that is able to boost the effectiveness of immunotherapy, a major new study reports. Scientists forced cancer cells in the lab to evolve much more rapidly than usual…
New Tool Monitors Real Time Mutations In Flu
A Rutgers-led team has developed a tool to monitor influenza A virus mutations in real time, which could help virologists learn how to stop viruses from replicating. The gold nanoparticle-based probe measures viral RNA in live influenza A cells, according to a study in The Journal of Physical Chemistry C. It is the first time in virology that experts have used imaging tools with gold nanoparticles to monitor mutations in influenza, with unparalleled sensitivity.
Geography, age and anemia shape childhood vaccine responses in Sub-Saharan Africa
Vaccine responses in the developing immune systems of children may depend on factors such as age, location and anemia status, according to a study comparing samples from 1,119 Dutch children to 171 children in sub-Saharan Africa who took part in…
Gaps in cure rate appear linked to race and insurance status for common HPV-related cancer
New study in JNCCN points to need for greater efforts to reduce racial disparities in cancer survival and increase access to appropriate health care
Gaps in cure rate appear linked to race and insurance status for common HPV-related cancer
New study in JNCCN points to need for greater efforts to reduce racial disparities in cancer survival and increase access to appropriate health care
Charting immune system development in sub-Saharan African children
Research aims to boost vaccination efficacy in the populations where it matters most
Development of the immune system varies according to age, location and anaemia
A study performed with children from Mozambique and Tanzania indicates that anaemia could reduce vaccine efficacy
New ACIP adult immunization schedule recommends changes to several vaccines
1. New ACIP Adult Immunization Schedule recommends changes to several vaccines ACIP now recommends shared decision-making for HPV, PCV13, and Meningitis B vaccines Abstract: http://annals. org/ aim/ article/ doi/ 10. 7326/ M20-0046 URL goes live when the embargo lifts The…
Poliovirus therapy shows potential as cancer vaccine in lab studies
Duke researchers use the modified virus to spur natural immune attack against tumors in animal studies